Glomerular matrix accumulation is linked to inhibition of the plasmin protease system

Kidney International

Volumn 42, Issue 6, 1992, Pages 1462-1469

  Tomooka, Suguru ^a   Border, Wayne A ^a   Marshall, Bruce C ^a   Noble, Nancy A ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; GLOMERULUS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0026480017     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1992.442     Document Type: Article

References (35)

1. KLAHR S, SCHREINER G, ICHIKAWA I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988
2. BROWNLESS M, CERAMI A: The biochemistry of the complications of diabetes mellitus. Ann Rev Biochem 50:385-432, 1981
3. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 86:453-462, 1990
4. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1. Nature 346:371-374, 1990
5. COIMBRA T, WIGGINS R, NOH JW, MERRETT S, PHAN SH: Transforming growth factor-β production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol 138:223-234, 1991
6. ROBERTS AB, SPORN MB: The transforming growth factor-βs, in Peptide Growth Factors and Their Receptors I, edited by SPORN MB, ROBERTS AB, Basal, Switzerland, Springer-Verlag, 1990, pp. 419-472
7. SPORN MB, ROBERTS AB, SHULL JH, SMITH JM, WARD JM: Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science 219:1329-1330, 1983
8. IONOTZ RA, MASSAGUE J: Type beta transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc Natl Acad Sci USA 8534:8550-8534, 1985
9. IGNOTZ RA, MASSAGUE J: Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345, 1986
10. ROBERTS AB, SPORN MB, ASSIAN RK, SMITH JM, ROCHE NS, WAKEFIELD LM, HEINE UI, LIOTTA LA, FALANGA V, KEHRL JH, FAUCI AS: Transforming growth factor type-β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171, 1986
11. CHEN J-K, HOSHI H, MCKEEHAN WL: Transforming growth factor type β specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc Natl Acad Sci USA 84:5287-5291, 1987
12. MORALES TI, ROBERTS AB: Transforming growth factor β regulates the metabolism of proteoglycans in bovine cartilage organ cultures. J Biol Chem 263:12828-12831, 1988
13. BASSOLS A, MASSAGUE J: Transforming growth factor β regulates the expression and structure of extracellular matrix chondroitin/ dermatan sulfate proteoglycans. J Biol Chem 263:3039-3045, 1988
14. IGNOTZ RA, MASSAGUE J: Cell adhesion protein receptors as targets for transforming growth factor-β action. Cell 51:189-197, 1987
15. HEINO J, IGNOTZ RA, HEMLER ME, CROUSE C, MASSAGUE J: Regulation of cell adhesion receptors by transforming growth factor-β. J Biol Chem 264:380-388, 1989
16. LAIHO M, SAKSELA O, ANDREASEN PA, KESKI-OJA J: Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J Cell Biol 103:2403-2410, 1986
17. LUND LR, RICCIO A, ANDREASEN AP, NIELSEN LS, KRISTENSEN P, LAIHO M, BLASI F, DANO K: Transforming growth factor-β is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J 6:1281-1286, 1987
18. EDWARDS DR, GILLIAN M, REYNOLDS JJ, WHITMAN SE, DOCHERTY AJP, ANGEL P, HEATH JK: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904, 1987
19. OVERALL CM, WRANA JL, SODEK J: Independent regulation of collagenase, 74-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J Biol Chem 264:1860-1869, 1989
20. VASSALLI J-D, SAPPINO A-P, BELIN D: The plasminogen activator/ plasmin system. J Clin Invest 88:1067-1072, 1991
21. ANDREASEN PA, GEORGE B, LUND LR, RICCIO A, STACEY SN: Plasminogen activator inhibitors: Hormonally regulated serpins. Mol Cell Endocrinol 68:1-19, 1990
22. IIDA H, SEIFERT R, ALPERS CE, GRONWALD RGK, PHILLIPS PE, PRITZL P, GORDON K, GOWN AM, ROSS R, BOWEN-POPE DF, JOHHNSON RJ: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 88:6560-6564, 1991
23. GERWIN BL, KESKI-OJA J, SEDDON M, LECHNER JF, HARRIS CC: TGF-β1 modulation of urokinase and PAI-1 expression in human bronchial epithelial cells. Am J Physiol 259 (Lung Cell Mol Physiol 3):L262-L269, 1990
24. NEWMAN MJ, LANE EA, IANNOTTI AM, NUGENT MA, PEPINSKY RB, KESKI-OJA J: Characterization and purification of a secreted plasminogen activator inhibitor (PAI-1) induced by transforming growth factor-β1 in normal rat kidney (NRK) cells: Decreased PAI-1 expression in transformed NRK cells. Endocrinology 126: 2936-2946, 1990
25. LOSKUTOFF DJ, SAWDEY M, MIMURO J: Type 1 plasminogen activator inhibitor. Progr Haemo Thromb 9:87-115, 1988
26. SAWDEY MS, LOSKUTOFF DJ: Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. J Clin Invest 88:1346-1353, 1991
27. LAEMMLI UK: Cleavage of structural proteins during assembly of the head of the bacteriophage T4. Nature 227:680-685, 1970
28. MARSHALL BC, SAGESER DS, RAO NV, EMI M, HOIDAL JR: Alveolar epithelial cell plasminogen activator. J Biol Chem 265: 9198-8204, 1990
29. VASSALLI J-D, BELIN D: Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 214:187-191, 1987
30. GRANELLI-PIPERNO A, REICH E: A study of proteases and protease inhibitor complexes in biological fluids. J Exp Med 148:223-234, 1978
31. BERMAN JW, BASCH RS: Amplification of the biotin-avidin immunofluorescence technique. J Immunol Meth 36:335-338, 1980
32. MILLER DE, NOBLE NA, YU X, BORDER WA: Molecular and cellular biological techniques in the study of glomerular disease. Semin Nephrol (in press)
33. MIMURO J, SCHLEEF RR, LOSKUTOFF DJ: Extracellular matrix of cultured bovine aortic endothelial cells contain functionally active type 1 plasminogen activator inhibitor. Blood 70:721-728, 1987
34. MAJACK RA, MAJESKY MW, GOODMAN LV: Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β. J Cell Biol 111:239-247, 1990
35. OLSEN D, POLLANEN J, HOYER-HANSEN G, RONNE E, SAKAGUCHI K, WUN T-C, APPELLA E, DANO K, BLASI F: Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. J Biol Chem 267:9129-9133, 1992